T

the-clinical-trials-network,-(ctnx)

lightning_bolt Market Research

The Clinical Trials Network (CTNx) Market Research Report



Background



Overview

The Clinical Trials Network (CTNx) is a physician-founded organization established in 2016 by Dr. Keith Friedenberg, a practicing gastroenterologist with nearly 20 years of research experience. Dr. Friedenberg's firsthand challenges in building a successful research program inspired the creation of CTNx, aiming to assist fellow physicians in navigating the complexities of clinical research.

Mission and Vision

CTNx's mission is to empower private practices, multi-specialty groups, and hospital systems to excel in clinical research by providing comprehensive support and resources. The organization envisions a future where community physicians have seamless access to clinical trials, thereby enhancing patient care and advancing medical knowledge.

Primary Area of Focus

CTNx specializes in clinical trial management and study start-up support, focusing on optimizing research efforts for private practices, sponsors, contract research organizations (CROs), multi-specialty groups, and hospital systems. The organization operates across various medical specialties, including gastroenterology, ophthalmology, dermatology, allergy/immunology, pulmonology, neurology/psychiatry, cardiology, rheumatology, endocrinology, and women's health.

Industry Significance

By facilitating the integration of clinical trials into community-based practices, CTNx plays a pivotal role in expanding access to cutting-edge treatments and advancing medical research. Its model addresses the challenges faced by private practices in initiating and managing clinical trials, thereby contributing to the diversification and inclusivity of clinical research.

Key Strategic Focus



Core Objectives

  • Accelerated Start-Up: Streamlining the initiation of clinical trials to reduce start-up times, thereby enabling faster patient enrollment and data collection.


  • Comprehensive Support: Providing centralized administrative support and in-house clinical research coordinator training to assist both novice and experienced investigators.


  • Diversity and Inclusion: Enhancing access to clinical trials for diverse patient populations, ensuring that research findings are broadly applicable.


Specific Areas of Specialization

  • Clinical Trial Management: Overseeing all aspects of clinical trials, from feasibility assessments to regulatory compliance and data management.


  • Site Development: Assisting private practices and multi-specialty groups in establishing and scaling successful research programs.


  • Patient Recruitment: Implementing strategies to identify and enroll eligible patients, thereby improving recruitment efficiency.


Key Technologies Utilized

  • Clinical Trial Management Systems (CTMS): Employing advanced CTMS platforms to monitor trial progress, manage data, and ensure compliance.


  • Electronic Data Capture (EDC): Utilizing EDC systems for accurate and efficient data collection and management.


  • Artificial Intelligence (AI): Partnering with AI-driven platforms like SelectIQ to enhance patient recruitment by analyzing electronic medical records for trial eligibility.


Primary Markets or Conditions Targeted

CTNx focuses on a wide range of medical specialties, including:

  • Gastroenterology


  • Ophthalmology


  • Dermatology


  • Allergy/Immunology


  • Pulmonology


  • Neurology/Psychiatry


  • Cardiology


  • Rheumatology


  • Endocrinology


  • Women's Health


Financials and Funding



Funding History

Specific details regarding CTNx's total funds raised and recent funding rounds are not publicly disclosed. The organization operates as a private entity, and financial information is not readily available.

Notable Investors

Information about individual investors or venture capital backing is not publicly disclosed.

Intended Utilization of Capital

While specific utilization details are not available, it is reasonable to infer that any capital raised would be directed towards:

  • Expansion of Services: Enhancing support for additional medical specialties and increasing the number of research sites.


  • Technological Advancements: Investing in state-of-the-art clinical trial management and data analysis tools.


  • Staff Development: Training and hiring personnel to support the growing network of research sites.


Pipeline Development



Key Pipeline Candidates

As a clinical trial management organization, CTNx does not develop its own pharmaceutical products. Instead, it facilitates the development of various pipeline candidates by partnering with pharmaceutical companies and CROs to conduct clinical trials across multiple therapeutic areas.

Stages of Clinical Trials or Product Development

CTNx supports clinical trials at all stages, including:

  • Phase I: Assessing safety and dosage.


  • Phase II: Evaluating efficacy and side effects.


  • Phase III: Confirming effectiveness, monitoring side effects, and comparing with standard treatments.


  • Phase IV: Post-marketing surveillance to detect long-term effects.


Target Conditions

The organization facilitates trials targeting a broad spectrum of conditions within its specialized medical fields, including:

  • Chronic diseases


  • Autoimmune disorders


  • Neurological conditions


  • Cardiovascular diseases


  • Endocrine disorders


  • Women's health issues


Relevant Timelines for Anticipated Milestones

Specific timelines for clinical trial milestones are determined by the sponsors and are not publicly disclosed. CTNx's role is to ensure efficient trial initiation and management, adhering to the sponsors' timelines.

Technological Platform and Innovation



Proprietary Technologies

CTNx utilizes proprietary systems for:

  • Clinical Trial Management: Ensuring streamlined operations across multiple research sites.


  • Data Transcription: Reducing the administrative burden on research coordinators by handling data entry into sponsor systems.


Significant Scientific Methods

  • Feasibility Assessments: Conducting thorough evaluations to determine site suitability for specific trials.


  • Centralized Administrative Support: Providing comprehensive support to manage regulatory documents, budgets, and contracts.


  • Clinical Research Coordinator Training: Offering in-house programs to equip coordinators with necessary skills and certifications.


AI-Driven Capabilities

CTNx has partnered with SelectIQ, an AI-powered platform, to enhance patient recruitment by analyzing electronic medical records to identify and pre-screen potential study candidates.

Leadership Team



Key Executive Profiles

  • Dr. Keith Friedenberg: Founder and CEO. A practicing gastroenterologist with nearly 20 years of research experience, Dr. Friedenberg established CTNx to assist physicians in integrating clinical trials into their practices.


  • Christopher Petek: President. Oversees operations and strategic initiatives, focusing on expanding CTNx's network and enhancing service offerings.


  • Mikayla: Site Engagement Officer. Works directly with new research sites to guide them through the onboarding process and ensure successful integration into the CTNx network.


Leadership Changes

No significant leadership changes have been publicly reported.

Competitor Profile



Market Insights and Dynamics

The clinical trial management industry is experiencing growth due to increasing demand for efficient trial processes and diverse patient recruitment. Organizations like CTNx are pivotal in bridging the gap between sponsors and community-based practices.

Competitor Analysis

  • IQVIA Holdings Inc.: A global leader in advanced analytics, technology solutions, and contract research services.


  • Syneos Health, Inc.: A biopharmaceutical solutions organization offering integrated biopharmaceutical solutions.


  • PPD (Thermo Fisher Scientific): Provides comprehensive, integrated drug development and laboratory services.


  • ICON plc: A global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries.


  • Charles River Laboratories: Offers comprehensive preclinical and clinical laboratory services.


  • Medpace Holdings, Inc.: A full-service global clinical contract research organization.


  • PRA Health Sciences (ICON): Provides outsourced clinical development and data solution services.


  • Clinical Research Solutions: Specializes in providing clinical research services.


  • Alliance for Clinical

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI